ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
8.38
+0.13 (1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
8.35
-0.03 (-0.36%)
After-hours: Apr 28, 2026, 4:10 PM EDT
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $75.81 million as of April 28, 2026. Its market cap has increased by 66.63% in one year.
Market Cap
75.81M
Enterprise Value
84.75M
1-Year Change
66.63%
Ranking
Category
Stock Price
$8.38
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $75.81M, an increase of 3,705.83%. That is a compound annual growth rate of 11.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 77.38M |
| MAIA Biotechnology | 77.05M |
| aTyr Pharma | 76.98M |
| PMV Pharmaceuticals | 76.79M |
| Pliant Therapeutics | 76.77M |
| XBiotech | 76.52M |
| TScan Therapeutics | 75.73M |
| Fortress Biotech | 75.03M |